These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25885367)

  • 1. Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence.
    Baller JB; McGinty EE; Azrin ST; Juliano-Bult D; Daumit GL
    BMC Psychiatry; 2015 Mar; 15():55. PubMed ID: 25885367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of cardiovascular risk factors in patients with schizophrenia and patients treated with antipsychotic drugs: are we equally exhaustive as with the general population?
    Castillo-Sánchez M; Fàbregas-Escurriola M; Bergè-Baquero D; Fernández-SanMartín M; Goday-Arno A
    Clin Exp Hypertens; 2017; 39(5):441-447. PubMed ID: 28590147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and Cardiovascular Care Among People with Severe Mental Illness: A Literature Review.
    Mangurian C; Newcomer JW; Modlin C; Schillinger D
    J Gen Intern Med; 2016 Sep; 31(9):1083-91. PubMed ID: 27149967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-review of lifestyle interventions for cardiovascular risk factors in the general medical population: lessons for individuals with serious mental illness.
    Ward MC; White DT; Druss BG
    J Clin Psychiatry; 2015 Apr; 76(4):e477-86. PubMed ID: 25919840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk screening of patients with serious mental illness or use of antipsychotics in family practice.
    Jakobs KM; Posthuma A; de Grauw WJC; Schalk BWM; Akkermans RP; Lucassen P; Schermer T; Assendelft WJJ; Biermans MJC
    BMC Fam Pract; 2020 Jul; 21(1):153. PubMed ID: 32727372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular preventive care for patients with serious mental illness.
    Ritchie S; Muldoon L
    Can Fam Physician; 2017 Nov; 63(11):e483-e487. PubMed ID: 29138173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk screening for individuals with serious mental illness.
    Black DR; Held ML
    Soc Work Health Care; 2017 Oct; 56(9):809-821. PubMed ID: 28771089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic monitoring for patients treated with antipsychotic medications.
    Cohn TA; Sernyak MJ
    Can J Psychiatry; 2006 Jul; 51(8):492-501. PubMed ID: 16933586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing cardiometabolic risk during treatment with antipsychotic medications.
    Amiel JM; Mangurian CV; Ganguli R; Newcomer JW
    Curr Opin Psychiatry; 2008 Nov; 21(6):613-8. PubMed ID: 18852570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review.
    McGinty EE; Baller J; Azrin ST; Juliano-Bult D; Daumit GL
    Schizophr Bull; 2016 Jan; 42(1):96-124. PubMed ID: 26221050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic medications: metabolic and cardiovascular risk.
    Newcomer JW
    J Clin Psychiatry; 2007; 68 Suppl 4():8-13. PubMed ID: 17539694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk factors in chronic treatment with antipsychotic agents used in primary care.
    Mundet-Tudurí X; Iglesias-Rodal M; Olmos-Domínguez C; Bernard-Antoranz ML; Fernández-San Martín MI; Amado-Guirado E
    Rev Neurol; 2013 Dec; 57(11):495-503. PubMed ID: 24265143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health behaviour beliefs and physical health risk factors for cardiovascular disease in an outpatient sample of consumers with a severe mental illness: a cross-sectional survey.
    Brunero S; Lamont S
    Int J Nurs Stud; 2010 Jun; 47(6):753-60. PubMed ID: 19959166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic issues and cardiovascular disease in patients with psychiatric disorders.
    Casey DE
    Am J Med; 2005 Apr; 118 Suppl 2():15S-22S. PubMed ID: 15903291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: a controlled study.
    Jennex A; Gardner DM
    Can J Psychiatry; 2008 Jan; 53(1):34-42. PubMed ID: 18286870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic Screening for CVD Risk Factors: The Dubai Shopping for Cardiovascular Risk Study (DISCOVERY).
    Yusufali A; Bazargani N; Muhammed K; Gabroun A; AlMazrooei A; Agrawal A; Al-Mulla A; Hajat C; Baslaib F; Philip J; Gupta P; Bakir S; Krishnan S; Almahmeed W; Alsheikh-Ali A
    Glob Heart; 2015 Dec; 10(4):265-72. PubMed ID: 26271552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing a Care Continuum for Cardiometabolic Conditions for Patients with Serious Mental Illness.
    Murphy KA; Daumit GL
    Curr Cardiol Rep; 2023 Apr; 25(4):193-202. PubMed ID: 36847991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
    Rzewuska M
    Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.